Magnetic resonance perfusion image features uncover an angiogenic subgroup of glioblastoma patients with poor survival and better response to antiangiogenic treatment

BACKGROUND. In previous clinical trials, antiangiogenic therapies such as bevacizumab did not show efficacy in patients with newly diagnosed glioblastoma (GBM). This may be a result of the heterogeneity of GBM, which has a variety of imaging-based phenotypes and gene expression patterns. In this stu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Liu, Tiffany T., Achrol, Achal S., Mitchell, Lex A., Rodriguez, Scott A., Feroze, Abdullah, Iv, Michael, Kim, Christine, Chaudhary, Navjot, Gevaert, Olivier, Stuart, Josh M., Harsh, Griffith R., Chang, Steven D., Rubin, Daniel L.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Basic and Translational Investigations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5570189/
https://ncbi.nlm.nih.gov/pubmed/28007759
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now270
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados